Company / Cash per Share
Editas Medicine, Inc. Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.77
FY2025
5-year range
$1.61 / $3.25
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $1.77.
Based on SEC 10-K filings.
1.77 in FY2025 with a 5-year CAGR of -7.2%.
Declined from $2.06 to $1.77 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- -7.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 10.2% year-over-year.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.77 | +10.2% |
| FY2024 | $1.61 | -21.7% |
| FY2023 | $2.06 | -0.6% |
| FY2022 | $2.07 | -36.4% |
| FY2021 | $3.25 | +26.6% |
| FY2020 | $2.57 | -47.4% |
| FY2019 | $4.88 | +48.3% |
| FY2018 | $3.29 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026